Found 22 matching trials
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT PHASE2 This phase II trial studies how well combination chemotherapy works in trea...
Show More Location
Children's Hospital of Alabama
Learn More & Join Trial
Therapy for Patients With Untreated Age-Adjusted International Prognostic Index Low-Intermediate Risk, High-Intermediate Risk, or High Risk Diffuse Large B Cell Lymphoma PHASE2 About 60% of patients with DLBCL can be cured with a chemotherapy program. ...
Show More Location
Memorial Sloan Kettering Cancer Center
Treatments Being Tested
Etoposide, carboplatin, ifosfamide Rituximab, Ifosfamide, Etoposide, Carboplatin Rituximab, Ifosfamide, Etoposide, Carboplatin, Stem Cell Collection, Mitoxantrone, Cyclophosphamide and etoposide, Carmustine Learn More & Join Trial
Response-based Treatment of High-risk Neuroblastoma PHASE2 The purpose of this study is to improve outcome of high risk neuroblastoma ...
Show More Location
Samsung Medical Center
Learn More & Join Trial
A Prospective Study of PD-1 Inhibitor Combined With ICE in the Treatment of Relapsed/Refractory Gray Area Lymphoma PHASE2 There are no standard chemotherapy regimens for relapse/refractory gray are...
Show More Location
Multiple Locations
Learn More & Join Trial
Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma PHASE3 This study utilizes a prospective, multicenter, randomized two-arm design t...
Show More Location
Dongyang People's Hospital
Learn More & Join Trial
Novel Targeted Drugs Combined With R-ICE Regimen in Relapsed and Refractory Diffuse Large B-cell Lymphoma PHASE2 A single-center, open, single-arm clinical study of the efficacy and safety...
Show More Learn More & Join Trial
Linperlisib Combined With Immunochemotherapy in Relapsed/Refractory LBCL PHASE2 To evaluate the efficacy and safety of Linperlisib combined with standard i...
Show More Location
Institute of Hematology & Blood Disease Hospital
Learn More & Join Trial
Salvage Chemotherapy for Poor Prognosis Germ Cell Tumors PHASE1 High-dose chemotherapy with autologous hematopoietic stem-cell transplantat...
Show More Learn More & Join Trial
Safety and Efficacy Trial of Epcoritamab Combinations in Subjects With B-cell Non-Hodgkin Lymphoma (B-NHL) PHASE1 The purpose of this trial is to measure the safety and effectiveness of epc...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Treatments Being Tested
rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone rituximab and lenalidomide rituximab and bendamustine rituximab, cytarabine, dexamethasone, and oxaliplatin/carboplatin gemcitabine and oxaliplatin Epcoritamab rituximab, cyclophosphamide, reduced dose of doxorubicin, vincristine, and prednisone Lenalidomide rituximab, ifosfamide, carboplatin, and etoposide phosphate Epcoritamab Epcoritamab Epcoritamab Epcoritamab Epcoritamab Epcoritamab Epcoritamab Rituximab and Lenalidomide Epcoritamab Learn More & Join Trial
New Combination of Chemoimmunotherapy for Systemic B-cell Lymphoma With Central Nervous System Involvement PHASE2 This is an open, non comparative, multicentre phase II trial, to evaluate t...
Show More Location
Facultni nemocnice
Learn More & Join Trial